Minor tissue absorbers can distinguish benign and malignant breast lesions using broadband quantitative diffuse optical spectroscopy

Sandhya Vasudevan; Christopher Campbell; Fang Liu; Thomas D. O'Sullivan

doi:10.1117/12.2578603

5 March 2021 Minor tissue absorbers can distinguish benign and malignant breast lesions using broadband quantitative diffuse optical spectroscopy

Sandhya Vasudevan, Christopher Campbell, Fang Liu, Thomas D. O'Sullivan

Author Affiliations +

Proceedings Volume 11639, Optical Tomography and Spectroscopy of Tissue XIV; 1163906 (2021) https://doi.org/10.1117/12.2578603
Event: SPIE BiOS, 2021, Online Only

Abstract

Noninvasive diffuse optical spectroscopy (DOS) is promising as an adjunct diagnostic imaging technique for distinguishing benign and malignant breast lesions. However, most DOS approaches require normalizing lesion optical biomarkers to healthy values in reference tissue since major tissue constituents exhibit large inter-patient variations. Our goal is to determine whether absolute measurements of minor optical absorbers such as collagen and methemoglobin (metHb) can successfully distinguish benign and malignant breast lesions. In this retrospective clinical study, 30 lesions with BIRADS score >= 3 (12 benign and 18 malignant lesions from 28 subjects) measured with broadband quantitative DOS were analyzed for their oxy-, deoxy- hemoglobin, water, lipids, collagen, and metHb concentrations as well as their optical scattering characteristics. Amongst all absolute DOS parameters (i.e., without normalization to healthy tissue) considered, only absolute metHb was observed to be significant for lesion discrimination (0.43±0.18 μM for benign vs 0.87±0.32 μM for malignant, p = 0.0002). Our findings demonstrate that lesion metHb concentration measured by quantitative DOS can improve noninvasive optical diagnosis of breast malignancies.

Conference Presentation

Citation Download Citation

Sandhya Vasudevan, Christopher Campbell, Fang Liu, and Thomas D. O'Sullivan "Minor tissue absorbers can distinguish benign and malignant breast lesions using broadband quantitative diffuse optical spectroscopy", Proc. SPIE 11639, Optical Tomography and Spectroscopy of Tissue XIV, 1163906 (5 March 2021); https://doi.org/10.1117/12.2578603

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available